Published in
Elsevier, Pulmonary Pharmacology and Therapeutics, (44), p. 61-69
DOI: 10.1016/j.pupt.2017.03.003
Links
Tools
XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts
Journal article published in 2017 by
Koichiro Kamio,
Arata Azuma 
,
Jiro Usuki,
Kuniko Matsuda,
Minoru Inomata,
Nobuhiko Nishijima,
Shioto Itakura,
Hiroki Hayashi,
Takeru Kashiwada,
Nariaki Kokuho,
Kenichiro Atsumi,
Tomoyoshi Yamaguchi,
Kazue Fujita,
Yoshinobu Saito,
Shinji Abe
and other authors.
,
Jiro Usuki,
Kuniko Matsuda,
Minoru Inomata,
Nobuhiko Nishijima,
Shioto Itakura,
Hiroki Hayashi,
Takeru Kashiwada,
Nariaki Kokuho,
Kenichiro Atsumi,
Tomoyoshi Yamaguchi,
Kazue Fujita,
Yoshinobu Saito,
Shinji Abe
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 